Alcohol addiction causes almost 3.8 per cent of deaths worldwide but a study led by Queensland University of Technology (QUT) researchers offers new hope in the form of a drug already approved by the Food and Drug Administration (FDA).
Neuroscientist Professor Selena Bartlett said the drug, pindolol, is an inexpensive approach for treating alcohol dependence once the human clinical trials are conducted.
Pinadol is an FDA-approved beta-blocker already used to treat high blood pressure and angina.
“Drugs currently used for AUDs (alcohol use disorders): acamprosate, naltrexone and disulfiram have limited success so this is a groundbreaking development with enormous potential,” said Professor Bartlett.
The study showed pindolol was able to reduce ethanol/alcohol consumption, particularly in relation to binge drinking, a key behaviour observed in human alcohol dependence.
Researcher Omkar Patkar said more research is required but the team believes pindolol represents a “novel, safe and ready to test treatment therapy option for managing alcohol dependence in humans.”
Read more here: Queensland University of Technology.